abstract |
(57) Abstract: A therapeutic agent for pain, comprising dibucaine or a physiologically acceptable salt thereof, a physiologically acceptable salt of salicylic acid, and calcium bromide. [Effect] The pain therapeutic agent of the present invention has an enhanced analgesic effect as compared with administration of dibucaine alone, shortens the time required for the onset of the effect, and further prolongs the duration. Useful for prevention. In addition, since the recovery process is good and the active state is recovered after an appropriate time, it can be used clinically safely. |